Suppr超能文献

大鼠肝脏和成纤维细胞中胰岛素样生长因子低分子量载体蛋白的生物合成。

Biosynthesis of the low molecular weight carrier protein for insulin-like growth factors in rat liver and fibroblasts.

作者信息

Romanus J A, Yang Y W, Nissley S P, Rechler M M

出版信息

Endocrinology. 1987 Sep;121(3):1041-50. doi: 10.1210/endo-121-3-1041.

Abstract

Biosynthesis of the low mol wt (Mr) carrier protein for insulin-like growth factors (IGFs) was studied in the BRL-3A rat liver cell line, rat embryo fibroblasts (REFs), and fetal rat liver by biosynthetic labeling of intact cells and cell-free translation of extracted RNA. [35S]Cysteine-labeled carrier protein precursors were immunoprecipitated using antibodies raised to the approximately 33,000 Mr carrier protein from BRL-3A cells that recognize the IGF carrier protein present in fetal and neonatal rat serum, but not in adult rat serum. The IGF carrier protein is synthesized as a 35,000 Mr precursor in a reticulocyte lysate translation system directed by RNA from BRL-3A cells or REFs. Supplementation of the translation incubation with microsomal membranes decreases the size of the precursor to 33,000 Mr, presumably by removal of a signal peptide. In continuous labeling or pulse-chase experiments of intact BRL-3A cells or REFs, the 33,000 Mr protein is labeled within 10 min intracellularly, appears in the medium after 40 min, and persists in the medium for 24 h without a change in size. The intracellular carrier protein was biosynthetically labeled in BRL-3A cells with [3H]leucine, [3H]phenylalanine, [3H]arginine, or [35S]cysteine and purified, and its NH2-terminal amino acid sequence was determined. Eleven of 34 residues were identified and correspond to those of mature unlabeled carrier protein purified from conditioned medium, indicating that after removal of the signal peptide, the carrier protein undergoes no detectable further processing at its NH2-terminus. These results establish that although they are regulated coordinately, IGF-II and the fetal IGF carrier protein are synthesized as separate proteins. Finally, RNA extracted from fetal, but not adult, rat liver directs the synthesis of the 35,000 Mr carrier protein precursor, suggesting that the developmental regulation of the carrier protein may occur at the level of RNA abundance.

摘要

通过完整细胞的生物合成标记以及提取RNA的无细胞翻译,在BRL - 3A大鼠肝细胞系、大鼠胚胎成纤维细胞(REFs)和胎鼠肝脏中研究了胰岛素样生长因子(IGF)低分子量(Mr)载体蛋白的生物合成。使用针对BRL - 3A细胞中约33,000 Mr载体蛋白产生的抗体免疫沉淀[35S]半胱氨酸标记的载体蛋白前体,该抗体可识别胎鼠和新生鼠血清中存在的IGF载体蛋白,但不能识别成年大鼠血清中的该蛋白。在由BRL - 3A细胞或REFs的RNA指导的网织红细胞裂解物翻译系统中,IGF载体蛋白作为35,000 Mr的前体合成。用微粒体膜补充翻译孵育体系可将前体大小降至33,000 Mr,推测是通过去除信号肽实现的。在完整的BRL - 3A细胞或REFs的连续标记或脉冲追踪实验中,33,000 Mr的蛋白在细胞内10分钟内被标记,40分钟后出现在培养基中,并在培养基中持续存在24小时,大小不变。用[3H]亮氨酸、[3H]苯丙氨酸、[3H]精氨酸或[35S]半胱氨酸对BRL - 3A细胞中的细胞内载体蛋白进行生物合成标记并纯化,测定其NH2 - 末端氨基酸序列。34个残基中有11个被鉴定出来,与从条件培养基中纯化的成熟未标记载体蛋白的残基一致,这表明在去除信号肽后,载体蛋白在其NH2 - 末端没有可检测到的进一步加工。这些结果表明,尽管IGF - II和胎儿IGF载体蛋白受到协调调节,但它们是作为单独的蛋白质合成的。最后,从胎鼠肝脏而非成年大鼠肝脏中提取的RNA指导35,000 Mr载体蛋白前体的合成,这表明载体蛋白的发育调节可能发生在RNA丰度水平。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验